Cell And Gene Articles, App Notes, Case Studies, & White Papers

  1. A Non-Viral Workflow For Modifying Primary T Cells 10/11/2024

    This study demonstrates the ability of combined platforms with complimentary technologies to modify primary T cells in a functionally-closed, automated fashion.

  2. Rapid Production Of Assay Ready Cells For GPCR Drug Discovery 7/29/2025

    Accelerate drug discovery by leveraging transiently transfected assay-ready cells. This method improves assay sensitivity and reduces variability for GPCRs.

  3. Comprehensive Pathway To Seamless Scale-Up Of mRNA DP Manufacturing 7/31/2024

    An integrated approach to mRNA drug product manufacturing helps to accelerate drug development, mitigate risks, and ultimately deliver life-changing therapies to patients.

  4. Don't Let Distribution Derail Your CGT Launch 8/7/2025

    Overcoming distribution challenges is critical for the success of cell and gene therapies. Learn how to build a flexible, robust strategy to optimize patient access.

  5. Is Sustainability The Key To Agile Biopharma Manufacturing? 3/18/2025

    In biologics manufacturing, change is constant. Discover how new innovations and a focus on sustainability have gotten 62% of executives to prioritize eco-friendly practices, which reflects a commitment to long-term viability.

  6. Fully Automated Cell Culture Passaging And Expansion 3/31/2025

    Automating cell culture tasks can reduce human error and free scientists from labor-intensive routines. Discover how imaging and automated systems enhance accuracy and reproducibility in cell culture processes.

  7. 8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development 2/3/2025

    Explore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.

  8. Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future 9/16/2025

    See why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.

  9. Biocompatibility Studies On CHO Cell Culture In X-ray Irradiated BioBLU® Single-Use Bioreactors 9/5/2024

    In cell culture, the leakage of toxic or inhibitory chemicals from single-use bioreactors has become a growing concern. Explore recommendations for leachable studies.

  10. NDA Success Strategy: Using Non-US Clinical Data In An NDA Submission 8/12/2025

    A sponsor acquiring a therapeutic asset from an overseas company sought assistance when including foreign clinical trial dat,a generated outside a U.S. IND, in a New Drug Application (NDA).